The role of IL28B as predictor of response to PEG-IFN+RBV therapy in patients with HCV-associated Mixed Cryoglobulinemia
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE / Teresa Urraro; Alessia Piluso; Carlo Giannini; Elisa Fognani; Laura Gragnani; Patrizio Caini; Monica Monti; Elisa Triboli; E Pellegrini; A Petrarca;Jessica Ranieri; Giacomo Laffi; Anna Linda Zignego. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - STAMPA. - 71:(2012), pp. 117-118.
ETIOLOGICAL THERAPY IN HCV-RELATED MIXED CRYOGLOBULINEMIA SYNDROME: THE ROLE OF IL28B GENOTYPE AS PREDICTOR OF RESPONSE
URRARO, TERESA;PILUSO, ALESSIA;FOGNANI, ELISA;GRAGNANI, LAURA;MONTI, MONICA;RANIERI, JESSICA;LAFFI, GIACOMO;ZIGNEGO, ANNA LINDA
2012
Abstract
The role of IL28B as predictor of response to PEG-IFN+RBV therapy in patients with HCV-associated Mixed Cryoglobulinemia
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
